Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable 5mg Tablet Under Fed Conditions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
Primary objective of the present study was to compare the single dose bioavailability of
Torrent's Montelukast Sodium chewable 5mg tablet and Innovator's(Merck)Singulair chewable 5mg
tablet. Dosing periods were separated by a washout period during fed study.
Study Design:
Open-Label, Randomised, two Period, two treatment, Crossover, Single-Dose Bioequivalence
Study